Search research articles
Contact Us
Filters
Showing results (291-300 of 321) with videos related to
Page
of 33
Sort By:
The Oncologist
|
November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
Luigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer
Robert Mutter, Bo Lu, David P Carbone, et al.
LGBT Health
|
March 26, 2024
Prevalence and Determinants of Cervicovaginal, Oral, and Anal Human Papillomavirus Infection in a Population of Transgender and Gender Diverse People Assigned Female at Birth
Ryan D McIntosh, Emily C Andrus, Heather M Walline, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
Cervicovaginal and anal self-sampling for HPV testing in a transgender and gender diverse population assigned female at birth: comfort, difficulty, and willingness to use
Erin F Welsh, Emily C Andrus, Claire B Sandler, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
Prevalence and determinants of cervicovaginal, oral, and anal HPV infection in a population of transgender and gender diverse people assigned female at birth
Ryan D McIntosh, Emily C Andrus, Heather M Walline, et al.
LGBT Health
|
April 4, 2024
Cervicovaginal and Anal Self-Sampling for Human Papillomavirus Testing in a Transgender and Gender Diverse Population Assigned Female at Birth: Comfort, Difficulty, and Willingness to Use
Erin F Welsh, Emily C Andrus, Claire B Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 24, 2012
Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab
H A Wakelee, S E Dahlberg, J R Brahmer, et al.
Clinical Lung Cancer
|
March 24, 2012
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer
Giorgio V Scagliotti, Silvia Novello, Joan H Schiller, et al.
The Oncologist
|
March 28, 2025
Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer
Mitchell S von Itzstein, Sawsan Rashdan, Suzanne E Dahlberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
Mark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 321) with videos related to
Sort By:
Page
of 33
The Oncologist
|
November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
Luigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer
Robert Mutter, Bo Lu, David P Carbone, et al.
LGBT Health
|
March 26, 2024
Prevalence and Determinants of Cervicovaginal, Oral, and Anal Human Papillomavirus Infection in a Population of Transgender and Gender Diverse People Assigned Female at Birth
Ryan D McIntosh, Emily C Andrus, Heather M Walline, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
Cervicovaginal and anal self-sampling for HPV testing in a transgender and gender diverse population assigned female at birth: comfort, difficulty, and willingness to use
Erin F Welsh, Emily C Andrus, Claire B Sandler, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
Prevalence and determinants of cervicovaginal, oral, and anal HPV infection in a population of transgender and gender diverse people assigned female at birth
Ryan D McIntosh, Emily C Andrus, Heather M Walline, et al.
LGBT Health
|
April 4, 2024
Cervicovaginal and Anal Self-Sampling for Human Papillomavirus Testing in a Transgender and Gender Diverse Population Assigned Female at Birth: Comfort, Difficulty, and Willingness to Use
Erin F Welsh, Emily C Andrus, Claire B Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 24, 2012
Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab
H A Wakelee, S E Dahlberg, J R Brahmer, et al.
Clinical Lung Cancer
|
March 24, 2012
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer
Giorgio V Scagliotti, Silvia Novello, Joan H Schiller, et al.
The Oncologist
|
March 28, 2025
Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer
Mitchell S von Itzstein, Sawsan Rashdan, Suzanne E Dahlberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
Mark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Page
of 33